Lepu Medical Technology (Beijing) Co., Ltd.
乐普医疗
300003
Shenzhen Stock Exchange
Company Profile
Lepu adheres to the innovation system of medical devices and drugs in accordance with the principle of "the generations of pre-research, registration, and production and sales". The major product, bioabsorbable vascular stent (NeoVas), which is researched and developed independently by our team, is a world revolution in the field of cardiovascular intervention. And following the registration of the homemade dual-chamber pacemaker, our GLP-1 exenatide and left atrial appendage occluder are going to be registered soon, which will fill the technology gap in China.In the next few years, there will be more than a dozen of major cardiovascular devices and medicine with the market capacity exceeding billions of dollars, which will further improve the cardiovascular drug platforms of research and development, supply and sales on anticoagulant, lipid-lowering, antihypertensive, heart failure, hypoglycemic and diabetic chronic diseases management, etc.Through Lepu's overall arrangement of cooperative hospitals in the major provinces, we aims at realizing the nationwide coverage of telemedicine services for the high-end medical resources of online hospital, and building cardiovascular health data platform and online & offline service network system centered on user-end. Orderly expand the fields of chronic diabetes management and new type cancer treatment, further develop new strategic businesses such as liquid biopsy and bio-innovative drugs, forming the core competitiveness of new technologies such as biopharmaceuticals, diabetes products and precision medicine to ensure a steady, high-speed and sustainable growth of the company, and to promote better returns for shareholders.
Full description
Lepu’s strategy is to build the company into a large-scale and eco-oriented global company that covers prevention, drug treatment, operation treatment and rehabilitation of cardiovascular diseases; to develop Lepu Medical into one of the largest supplier of cardiovascular related products and services on the platforms of medical device, medicine, health care products, health service and new medical mode; and to set up a comprehensive platform which extends to more than 20 densely populated provinces in China, that integrates online expert consultation and offline medical service for cardiovascular health. In the medical device section, in accordance with the principle of "pre-research generation, registration generation and production and sales generation", Lepu ensures the innovative products will be listed on a grading basis in the future, to realize the leap-forward growth of the company and lead the development of the industry. Lepu develops the innovative cardiovascular-related household intelligent medical devices and diagnostic reagents product line, promote the competitive power of researching & developing, producing and selling of IVD equipment and diagnostic reagents, to establish IVD platform. Expand the fields of major diseases related devices, ensuring the sustainable development of the medical device section. In the pharmaceutical section, Lepu promotes brand marketing for its developing strategy. Establish a researching, supplying and marketing platform on drugs of anticoagulant, lipid-lowering, antihypertensive, heart failure, hypoglycemic and chronic diabetes management, to set up the market-based competitive advantage in "clinical sales, OTC sales and third terminal sales" of cardiovascular drugs. Extend this section from the chemical medicine to the bio-innovative medicine. Gradually enhance the competitive power of new technologies such as biopharmaceuticals, and ensure the sustainable development of the pharmaceutical section. In the medical service section, Lepu builds cardiovascular remote network platform to provide services to the grassroots clinic medical service system of China’s main provinces or cities, establish intelligent mobile surveillance and online health management service system of cardiovascular health. And establish a comprehensive online and offline medical service platform for cardiovascular health in specialized cardiovascular hospitals in China’s main provinces. In the new medical mode section, Lepu aims at the future hotspots of medical health industry, through venture capital funds, industrial funds and direct investment and other means, promoting the core competitive power of new international technologies such as medical equipment, precision medicine and bio-pharmaceuticals, and gradually achieves technological breakthroughs in new fields, endeavor to become top-ranking enterprise in the field, and ensure stable, high-speed and sustainable development of the company.